Incite Genomics Pty Ltd

Site

Incite Genomics

Accreditation No.

20374

Site No.

24392

Date of Accreditation

30 Oct 2018

Address

2/24 Lakeside Drive
Burwood East, VIC 3151
Australia

Contact

Availability

Services available to external clients

Supervision

Not Applicable

Scope of Accreditation

Print scopes
Incite Genomics

ISO 15189 (2012)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Service Product Determinant
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes Buccal swabs ABC transporters; Bilirubin-UGT enzyme; Catechol-O-methyltransferase (COMT) pharmacogenomic studies; Cytochrome P450 pharmacogenomic studies; Dihydropyrimidine dehydrogenase (DPYD) genotyping; HLA-B27; Human carboxylesterase 1 (CES1) pharmacogenomic studies; Nudix hydrolase 15 gene (NUDT15); OPRM1 pharmacogenomic studies; SCL01B1 pharmacogenomic studies; Thiopurine methyltransferase (TPMT) genotyping; VKORC1 pharmacogenomic studies; α1-Antitrypsin
Molecular genetics - DNA extraction Buccal swabs Viable DNA

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.